Advertisement

Rheumatologic Diseases

  • Xiang-Yang Su
  • You-Shou Gu
  • Dong-Lai Ma
  • Shu-Xian Yan
  • Tao Qu
  • Ru-Zhi Zhang
  • Ding-Hua Kang
  • Li-Wen Ma
  • Cheng Tan
  • Wen-Yuan Zhu
Chapter

Abstract

Rheumatologic diseases have a diversity of cutaneous and systemic manifestations. This chapter presents with annular erythematous type of subacute cutaneous lupus erythematosus, bullous systemic lupus erythematosus, lupus erythematosus tumidus, neonatal lupus erythematosus, antiphospholipid syndrome, nodular scleroderma, atrophoderma of Pasini and Pierini, acrodermatitis chronica atrophicans, linear atrophoderma of Moulin, rheumatoid neutrophilic dermatitis, and graft-versus-host disease.

References

  1. 1.
    Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol. 2013;27(3):391–404.  https://doi.org/10.1016/j.berh.2013.07.008.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Chanprapaph K, Sawatwarakul S, Vachiramon V. A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients. Lupus. 2017;6(12):1278–84.  https://doi.org/10.1177/0961203317699714.CrossRefGoogle Scholar
  3. 3.
    Kreuter A, Tigges C, Hunzelmann N, Oellig F, Lehmann P, Hofmann SC. Rituximab in the treatment of recalcitrant generalized lupus erythematosus tumidus. J Dtsch Dermatol Ges. 2017;15(7):729–31.  https://doi.org/10.1111/ddg.13266.CrossRefPubMedGoogle Scholar
  4. 4.
    Stitt R, Fernelius C, Roberts J, Denunzio T, Arora NS. Lupus erythematosus tumidus: a unique disease entity. Hawaii J Med Public Health. 2014;73(9 Suppl 1):18–21.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Yokogawa N, Sumitomo N, Miura M, Shibuya K, Nagai H, Goto M, Murashima A. Neonatal lupus erythematosus. Nihon Rinsho Men'eki Gakkai kaishi. 2017;40(2):124–30.  https://doi.org/10.2177/jsci.40.124.CrossRefPubMedGoogle Scholar
  6. 6.
    Ibrahim U, Kedia S, Garcia G, Atallah JP. Antiphospholipid syndrome: multiple manifestations in a single patient-a high suspicion is still needed. Case Rep Med. 2017;2017:5797041.  https://doi.org/10.1155/2017/5797041.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Spierings J, Verstraeten VL, Vosse D. Nodular scleroderma. Arthritis Rheumatol. 2015;67(12):3157.  https://doi.org/10.1002/art.39325.CrossRefPubMedGoogle Scholar
  8. 8.
    Ling X, Shi X. Idiopathic atrophoderma of Pasini-Pierini associated with morphea: the same disease spectrum? Giornale italiano di dermatologia e venereologia: organo ufficiale. Societa italiana di dermatologia e sifilografia. 2016;151(1):127–8.Google Scholar
  9. 9.
    Amano H, Nagai Y, Ishikawa O. Multiple morphea coexistent with atrophoderma of Pasini-Pierini (APP): APP could be abortive morphea. J Eur Acad Dermatol Venereol. 2007;21(9):1254–6.  https://doi.org/10.1111/j.1468-3083.2006.02131.x.CrossRefPubMedGoogle Scholar
  10. 10.
    Stinco G, Trevisan G, Martina Patriarca M, Ruscio M, Di Meo N, Patrone P. Acrodermatitis chronica atrophicans of the face: a case report and a brief review of the literature. Acta Dermatovenerol Croat. 2014;22(3):205–8.PubMedGoogle Scholar
  11. 11.
    Darung I, Rudra O, Samanta A, Agarwal M, Ghosh A. Linear atrophoderma of moulin over face: an exceedingly rare entity. Indian J Dermatol. 2017;62(2):214–5.  https://doi.org/10.4103/ijd.IJD_469_16.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Kubota N, Ito M, Sakauchi M, Kobayashi K. Rheumatoid neutrophilic dermatitis in a patient taking tocilizumab for treatment of rheumatoid arthritis. J Dermatol. 2017;44(7):e180–1.  https://doi.org/10.1111/1346-8138.13824.CrossRefPubMedGoogle Scholar
  13. 13.
    Below J, Helbig D. Rheumatoid neutrophilic dermatitis. Hautarzt. 2015;66(4):228–30.  https://doi.org/10.1007/s00105-015-3594-0.CrossRefPubMedGoogle Scholar
  14. 14.
    Krivolapova A, Belousova IE, Smirnova IO, Lisukova EV, Baikov VV. Diagnosis of cutaneous graft-versus-host disease: pathomorphological aspects. Arkh Patol. 2014;76(4):24–8.PubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. and People's Military Medical Press 2018

Authors and Affiliations

  • Xiang-Yang Su
    • 1
  • You-Shou Gu
    • 2
  • Dong-Lai Ma
    • 3
  • Shu-Xian Yan
    • 4
  • Tao Qu
    • 3
  • Ru-Zhi Zhang
    • 5
  • Ding-Hua Kang
    • 5
  • Li-Wen Ma
    • 6
  • Cheng Tan
    • 7
  • Wen-Yuan Zhu
    • 6
  1. 1.Department of DermatologyThe Third Affiliated Hospital, Sun Yat-Sen UniversityGuangzhouChina
  2. 2.Guangdong Provincial Centre for Control of STD and DermatosisGuangzhouChina
  3. 3.Department of DermatologyPeking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
  4. 4.Department of DermatologyHuashan Hospital of Fudan UniversityShanghaiChina
  5. 5.Department of DermatologyThe Third Affiliated Hospital of Suzhou UniversityChangzhouChina
  6. 6.Department of DermatologyFirst Affiliated Hospital of Nanjing Medical UniversityNanjingChina
  7. 7.Department of DermatologyAffiliated Hospital of Nanjing University of Chinese MedicineNanjingChina

Personalised recommendations